AbbVie’s (ABBV) plan to close the $63 billion Allergan (AGN) deal this month appears on track following the announcement that they have received …
In a research note issued Friday, Deutsche Bank analyst Gregg Gilbert trimmed his EPS estimates for healthcare giants Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Teva Pharmaceutical (NYSE:TEVA), and Allergan plc …
Vitae Pharmaceuticals Inc (NASDAQ:VTAE) and Allergan plc (NYSE:AGN) announced that they have entered into a definitive agreement under which Allergan will acquire Vitae for $21.00 …
The recent merger between Allergan PLC (NYSE:AGN) and Pfizer is still the talk of the town despite fears that U.S.
Analysts from Mizuho Securities and Cannacord weigh in on biopharm companies Allergan PLC (NYSE:AGN) and Mallinckrodt PLC (NYSE:MNK) following Pfizer-Allergan merger deal and …
BTIG analyst Tim Chiang weighed in today with a cautious stance on the “Mega Inversion” deal between Pfizer Inc.(NYSE:PFE) and Allergan PLC (NYSE:AGN), where Pfizer would acquire Allergan …
Analysts are weighing in on the pharmaceutical giant Pfizer Inc. (NYSE:PFE) and specialty-drug giant Allergan PLC (NYSE:AGN), as the companies announce a merger that will …
RBC Capital Markets compiled a list in December 2014 of their top 30 global investment ideas for 2015 to shine light on the …